Jasmonates in cancer therapy

Cancer Letters

Volumn 245, Issue 1-2, 2007, Pages 1-10

  Flescher, Eliezer ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ATP; Bcl 2; Cancer; Differentiation; Drug; Drug resistance; HSP; Jasmonate; MAPK; Mitochondria; P gp; p53; Plant; ROS; Stress; Therapy

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; BRUCEANTIN; CAMPTOTHECIN; DOCETAXEL; ELLIPTINIUM; EPIPODOPHYLLOTOXIN; ETOPOSIDE; FLAVOPIRIDOL; GLYCOPROTEIN P; HEAT SHOCK PROTEIN; HOMOHARRINGTONINE; HYDROGEN PEROXIDE; IRINOTECAN; JASMONIC ACID; JASMONIC ACID METHYL ESTER; MITOGEN ACTIVATED PROTEIN KINASE; NAVELBINE; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; ROSCOVITINE; TENIPOSIDE; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINDESINE;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; BRONCHUS CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL CYCLE ARREST; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KAPOSI SARCOMA; LEUKEMIA CELL; LIFESPAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHOMA; MITOCHONDRION; NONHUMAN; OVARY CANCER; PLANT CELL; PRIORITY JOURNAL; PROTEIN FAMILY; SHORT SURVEY; SOLID TUMOR; SYSTEMATIC REVIEW; TESTIS CANCER;

EID: 33845642967     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.03.001     Document Type: Review

References (54)

1. Fingrut O., and Flescher E. Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 16 (2002) 608-616
2. Ishii Y., Kiyota H., Sakai S., and Honma Y. Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones. Leukemia 18 (2004) 1413-1419
3. Kim J.H., Lee S.Y., Oh S.Y., Han S.I., Park H.G., Yoo M.A., and Kang H.S. Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells. Oncol. Rep. 12 (2004) 1233-1238
4. Samaila D., Ezekwudo D.E., Yimam K.K., and Elegbede J.A. Bioactive plant compounds inhibited the proliferation and induced apoptosis in human cancer cell lines, in vitro. Trans. Integr. Biomed. Inform. Enabling Tech. Symp. J 1 (2004) 34-42. Published online at: www.tibetsjournal.org
5. Flescher E. Jasmonates-a new family of anti-cancer agents. Anti-Cancer Drugs 16 (2005) 911-916
6. Plant Hormones: Biosynthesis, Signal Transduction, Action. In: Davies P.J. (Ed) (2004), Kluwer, Dordrecht
7. Mukherjee A.K., Basu S., Sarkar N., and Ghosh A.C. Advances in cancer therapy with plant based natural products. Curr. Med. Chem. 8 (2001) 1467-1486
8. Cragg G.M., and Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100 (2005) 72-79
9. Kanadaswami C., Lee L.T., Lee P.P., Hwang J.J., Ke F.C., Huang Y.T., and Lee M.T. The antitumor activities of flavonoids. In Vivo 19 (2005) 895-909
10. De Mejia E.G., and Prisecaru V.I. Lectins as bioactive plant proteins: a potential in cancer treatment. Crit. Rev. Food Sci. Nutr. 45 (2005) 425-445
11. Umezawa K. Isolation and biological activities of signal transduction inhibitors from microorganisms and plants. Adv. Enzyme Regul. 35 (1995) 43-53
12. Singh R.P., Dhanalakshmi S., and Agarwal R. Phytochemicals as cell cycle modulators. Cell Cycle 1 (2002) 156-161
13. Hollosy F., and Keri G. Plant-derived protein tyrosine kinase inhibitors as anticancer agents. Curr. Med. Chem. Anti-Cancer Agents 4 (2004) 173-197
14. Ordan O., Rotem R., Jaspers I., and Flescher E. Stress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation. Br. J. Pharmacol. 138 (2003) 1156-1162
15. Rotem R., Tzivony Y., and Flescher E. Contrasting effects of aspirin on prostate cancer cells: suppression of proliferation and induction of drug resistance. Prostate 42 (2000) 172-180
16. Ishii Y., Hori Y., Sakai S., and Honma Y. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant-redifferentiation-inducing hormones. Cell Growth Differ. 13 (2002) 19-26
17. Vermeulen K., Strand M., Krystof V., Havlicek L., Van der Aa A., Lenjou M., et al. Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases. Leukemia 16 (2002) 299-305
18. Dolezal K., Popa I., Krystof V., Spichal L., Fojtikova M., Holub J., et al. Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells. Bioorg. Med. Chem. 14 (2006) 875-884
19. Constantini P., Jacotot E., Decaudin D., and Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl Cancer Inst. 92 (2000) 1042-1053
20. Rotem R., Heyfets A., Fingrut O., Blickstein D., Shaklai M., and Flescher E. Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res. 65 (2005) 1984-1993
21. Debatin K.-M., Poncet D., and Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21 (2002) 8786-8803
22. Newmeyer D.D., and Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112 (2003) 481-490
23. Chen L.B. Mitochondrial membrane potential in living cells. Ann. Rev. Cell Biol. 4 (1988) 155-181
24. Dang C.V., and Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 24 (1999) 68-72
25. Warburg O. The Metabolism of Tumors (1930), Constable, London
26. Cuezva J.M., Krajewska M., de Heredia M.L., Krajewski S., Santmaria G., Kim H., et al. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 62 (2002) 6674-6681
27. Isidoro A., Martinez M., Fernandez P.L., Ortega A.D., Santamaria G., Chamorro M., et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem. J. 378 (2004) 17-20
28. Fingrut O., Reischer D., Rotem R., Goldin N., Altboum I., Zan-Bar I., and Flescher E. Jasmonates induce non-apoptotic death in high-resistance mutant p53-expressing B lymphoma cells. Br. J. Pharmacol. 146 (2005) 800-808
29. Brtko J., and Thalhamer J. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention. Curr. Pharm. Des. 9 (2003) 2067-2077
30. Zhang J.W., Gu J., Wang Z.Y., Chen S.J., and Chen Z. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. J. Biosci. 25 (2000) 275-284
31. Schmutzler C., and Koehrle J. Innovative strategies for treatment of thyroid cancer. Eur. J. Endocrinol. 143 (2000) 15-24
32. Ishii Y., Kasukabe T., and Honma Y. Induction of CCAAT/enhancer binding protein-δ by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukemia cells. Br. J. Haematol. 128 (2005) 540-547
33. Ishii Y., Kasukabe T., and Honma Y. Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells. Biochim. Biophys. Acta 1745 (2005) 156-165
34. Oh S.Y., Kim J.H., Park M.J., Kim S.M., Yoon C.S., Joo Y.M., et al. Induction of heat shock protein 72 in C6 glioma cells by methyl jasmonate through ROS-dependent heat shock factor 1 activation. Int. J. Mol. Med. 16 (2005) 833-839
35. Asai T., Stone J.M., Heard J.E., Kovtun Y., Yorgey P., Sheen J., and Ausubel F.M. Fumonisin B1-induced cell death in Arabidopsis protoplasts requires jasmonate-, ethylene-, and salicylate-dependent signaling pathways. Plant Cell 12 (2000) 1823-1836
36. Naill M.C., and Roberts S.C. Cell cycle analysis of Taxus suspension cultures at the single cell level as an indicator of culture heterogeneity. Biotechnol. Bioeng. 90 (2005) 491-500
37. Swiatek A., Azmi A., Stals H., Inze D., and Van Onckelen H. Jasmonic acid prevents the accumulation of cyclin B1;1 and CDK-B in synchronized tobacco BY-2 cells. Fed. Eur. Biochem. Soc. Lett. 572 (2004) 118-122
38. Rotem R., Fingrut O., Moskovitz J., and Flescher E. The anticancer agent methyl jasmonate induces activation of stress-regulated c-Jun N-terminal kinase and p38 protein kinase in human lymphoid cells. Leukemia 17 (2003) 2230-2234
39. Agrawal G.K., Rakwal R., and Iwahashi H. Isolation of novel rice (Oryza sativa L.) multiple stress responsive MAP kinase gene, OsMRSMK2, whose mRNA accumulates rapidly in response to environmental cues. Biochem. Biophys. Res. Commun. 294 (2002) 1009-1016
40. Song F., and Goodman R.M. OsBIMK1, a rice MAP kinase gene involved in disease resistance responses. Planta 215 (2002) 997-1005
41. Agrawal G.K., Agrawal S.K., Shibato J., Iwahashi H., and Rakwal R. Novel rice MAP kinases OsMSRMK3 and OsWJUMK1 involved in encountering diverse environmental stresses and developmental regulation. Biochem. Biophys. Res. Commun. 300 (2003) 775-783
42. Kim J.A., Agrawal G.K., Rakwal R., Han K.S., Kim K.N., Yun C.H., et al. Molecular cloning and mRNA expression analysis of a novel rice (Oryza sativa L.) MAPK kinase kinase, OsEDR1, an ortholog of Arabidopsis AtEDR1, reveal its role in defense/stress signalling pathways and development. Biochem. Biophys. Res. Commun. 300 (2003) 868-876
43. Suhita D., Raghavendra A.S., Kwak J.M., and Vavasseur A. Cytoplasmic alkalization precedes reactive oxygen species production during methyl jasmonate- and abscisic acid-induced stomatal closure. Plant Physiol. 134 (2004) 1536-1545
44. Danon A., Miersch O., Felix G., Camp R.G., and Apel K. Concurrent activation of cell death-regulating signaling pathways by singlet oxygen in Arabidopsis thaliana. Plant J. 41 (2005) 68-80
45. Mittler R., Feng X., and Cohen M. Post-transcriptional suppression of cytosolic ascorbate peroxidase expression during pathogen-induced programmed cell death in tobacco. Plant Cell 10 (1998) 461-473
46. Kaukinen K.H., Tranbarger T.J., and Misra S. Post-termination-induced and hormonally dependent expression of low-molecular-weight heat shock protein genes in Douglas fir. Plant Mol. Biol. 30 (1996) 1115-1128
47. Hamilton III E.W., and Coleman J.S. Heat-shock proteins are induced in unstressed leaves of Nicotiana attenuata (Solanaceae) when distant leaves are stressed. Am. J. Bot. 88 (2001) 950-955
48. Willis A.C., and Chen X. The promise and obstacle of p53 as a cancer therapeutic agent. Curr. Mol. Med. 2 (2002) 329-345
49. Lowe S.W., and Ruley H.E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7 (1993) 535-545
50. Nelson W.G., and Kastan M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14 (1994) 1815-1823
51. Hansen R., and Oren M. p53: from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7 (1997) 46-51
52. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
53. Yeruva L.V., Elegbede J.A., Toy B.J., and Wang R.C. The apoptosis-inducing activity of natural plant products involved regulation of events downstream of the p53 pathway. Proc. Am Assoc. Cancer Res. 46 (2005) Abstract # 5902
54. E. Flescher, D. Reischer, O. Fingrut, A. Harel, I. Zan-Bar, Jasmonates can overcome drug resistance induced by p53 mutations and P-glycoprotein expression, Eur. J. Cancer, (Suppl. 3) (2005) 428.